Oxford Brain Diagnostics Ltd is rethinking how brain health is assessed and managed. Founded in neuropathological and neuroimaging expertise, the company’s patented Cortical Disarray Measurement (CDM®) technology uses MRI brain scan data to support early and differential diagnosis, track progression, and predict the decline of neurodegenerative diseases. Oxford Brain Diagnostics is committed to assessing brain health based on changes in the cellular structure, supporting drug development, and helping clinicians around the world in their fight to defeat Alzheimer’s and other neurodegenerative diseases.


Health Data

Life Sciences

Medical Devices

Oxford Brain Diagnostics Ltd

Steven Chance

Daniel Kaute

Nao Kamiya

Terry Pollard

Omar Ehsan

Ian Hardingham

Ged Ridgway

The Leadership Team at Oxford Brain Diagnostics Ltd is responsible for setting the strategic direction of the company, ensuring operational excellence, and driving commercial growth. Comprised of executives with expertise in commercial strategy, scientific research, technology development, and operational management, they collaborate to advance the application of the company's Cortical Disarray Measurement (CDM®) technology. Their goal is to revolutionize brain health assessments and improve clinical outcomes for neurodegenerative diseases globally.

Leadership Team

Engineering and Science

Leadership Team

About

Team members

Other teams at Oxford Brain Diagnostics Ltd

Engineering and Science